[144] Corcept Therapeutics Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 for Corcept Therapeutics (CORT) shows a proposed sale of 2,326 common shares acquired by stock option exercise on 08/22/2025, with cash payment the same day. The sale is through Fidelity Brokerage Services LLC on NASDAQ and the reported aggregate market value is $165,774.02. The filing also lists a prior sale on 06/16/2025 of 3,185 shares generating $225,402.45. The issuer’s outstanding shares are reported as 105,371,729. The filer certifies no undisclosed material adverse information is known.

Positive

• Disclosure compliance: The Form 144 provides required public notice of the intended sale, increasing transparency
• Transaction details provided: Acquisition method (stock option exercise), payment (cash), broker (Fidelity) and aggregate value are all stated

Negative

• Insider sales reported: A prior sale of 3,185 shares on 06/16/2025 and a proposed sale of 2,326 shares may be viewed unfavorably by some investors

Insights

Securities Analyst

TL;DR: Routine insider notice of planned sale following option exercise; size is immaterial relative to total shares.

The Form 144 documents a proposed sale of 2,326 shares resulting from a same-day option exercise and cash payment, listed with Fidelity and intended for sale on NASDAQ. The reported aggregate value of $165,774.02 and the prior 3,185-share sale (gross proceeds $225,402.45) are small versus 105.4 million shares outstanding, indicating limited direct impact on share supply or valuation. This filing fulfills Rule 144 disclosure requirements and provides transparency on insider liquidity events.

Corporate Governance Expert

TL;DR: Disclosure is compliant and routine; no governance red flags apparent from the filing alone.

The notice includes required representations about the absence of undisclosed material adverse information and documents the acquisition method (stock option exercise) and payment in cash. The presence of a prior sale in June is disclosed. There is no information in the filing suggesting unusual trading plans, related-party transfers, or material governance concerns; it appears to be a standard insider liquidity event reported under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2326	165774.02	105371729	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Stock Option Exercise	Issuer			2326	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gary C. Robb 101 Redwood Shores Parkway Redwood City CA 94065	Common	06/16/2025	3185	225402.45

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for CORT report for sale?

2,326 common shares acquired by stock option exercise on 08/22/2025, to be sold on NASDAQ through Fidelity Brokerage.

What is the aggregate market value reported for the proposed sale?

$165,774.02 is the aggregate market value reported for the 2,326 shares.

Were there any recent sales by the same person in the past three months?

Yes. A sale of 3,185 shares on 06/16/2025 with gross proceeds of $225,402.45 is disclosed.

How were the 2,326 shares acquired?

They were acquired by stock option exercise from the issuer on 08/22/2025 with payment in cash.

How many shares outstanding does the filing report for the issuer?

The filing reports 105,371,729 shares outstanding for the issuer.